TIDASVIQ
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Jan 2024)
What this means for you
This application is over — abandoned 22 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90505282
- Mark type
- Stylized text
- Filed
- 02 Feb 2021
- Published for opposition
- 26 Oct 2021
- Abandoned
- 22 Jan 2024
- Attorney of record
- Patrick J. Concannon
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis
Owner
- SUN PHARMACEUTICAL INDUSTRIES, INC., PRINCETON, NJ, US
- Concert Pharmaceuticals, Inc., Lexington, MA, US
- Concert Pharmaceuticals, Inc., Lexington, MA, US
Prosecution history
- 22 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jun 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Jun 2023 — SOU EXTENSION 3 GRANTED
- 13 Jun 2023 — SOU EXTENSION 3 FILED
- 13 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 10 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Dec 2022 — SOU EXTENSION 2 GRANTED
- 08 Dec 2022 — SOU EXTENSION 2 FILED
- 08 Dec 2022 — SOU TEAS EXTENSION RECEIVED
- 22 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jun 2022 — SOU EXTENSION 1 GRANTED
- 20 Jun 2022 — SOU EXTENSION 1 FILED
- 20 Jun 2022 — SOU TEAS EXTENSION RECEIVED